Harpoon Therapeutics Inc reports results for the quarter ended in March - Earnings Summary

Harpoon Therapeutics

11/05/2023 22:30

* Harpoon Therapeutics Inc  HARP.OQ  reported a quarterly
adjusted
loss of 31 cents​​ per share for the quarter ended in March. The
mean expectation of seven analysts for the quarter was for a
loss of 38 cents per share.
    * Revenue rose 45.3% to $8.58 million from a year ago;
analysts
expected $4.81 million. 
    * Harpoon Therapeutics Inc's reported EPS for the quarter
was a
loss of 31 cents​.
    * The mean earnings estimate of analysts had risen by
about 18% in
the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Harpoon Therapeutics Inc shares had risen by 6.9% this
quarter and gained 9.7% so far this year.
    * The company reported a quarterly loss of $11.39 million.
    * Wall Street's median 12-month price target for Harpoon
Therapeutics Inc is $5.25 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data May
11 at 09:30 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2023      -0.38          -0.31          Beat
 Dec. 31 2022      -0.47          -0.55          Missed
 Sep. 30 2022      -0.56          -0.35          Beat
 Jun. 30 2022      -0.56          -0.53          Beat